Browse Drug Recalls
14,380 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 14,380 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 14,380 FDA drug recalls, Class II.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jan 24, 2022 | PAIN TERMINATOR extra strength pain relief (aspirin 162 mg, acetaminophen 110... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Headache & Congestion Sinus Relief (acetaminophen 250 mg, phenylephrine HCl 5... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Maximum Strength Non Aspirin Pain Reliever/Fever Reducer (acetaminophen 500 m... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Ephedrine Plus (Ephedrine HCl 25mg, Guaifenesin 200mg) tablets, 24-count bott... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | PAPENOL (acetaminophen 500 mg), 2 tablet packets, Manufactured for: Afassco I... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Multi Symptom Cold Relief (acetaminophen 325 mg, Dextromethorphan HBr 15mg, G... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | FEM-PRIN MENSTRUAL RELIEF (acetaminophen 325 mg, pamabrom 25mg) tablets, 2-co... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | PEPTIME Energy (caffeine 350mg) tablets, packaged in a) 6 count packets and b... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Dologen (acetaminophen 325 mg and dexbrompheniramine maleate 1mg) caplets, pa... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Cold Relief (acetaminophen 250 mg, guaifenesin 200mg, phenylephrine HCl 5 mg)... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | DILOTAB II, SINUS AND COLD RELIEF NON DROWSY (acetaminophen 325 mg, Phenyleph... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | PEPTIME Energy (caffeine 250mg) tablets, packaged in a) 6 count packets and b... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Cetafen Non-aspirin pain reliever (acetaminophen 325mg) tablets, 2-count pac... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | PAINAID BRF Back Relief Formula (acetaminophen 250 mg, caffeine 50 mg, Magnes... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | CVS Health Natural Sleep Aid Chewable Tablets Cherry Flavor (melatonin 1.5mg)... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Nasal & Sinus Decongestant (phenylephrine HCl 5mg) 2 tablets per packet, Mfd.... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 21, 2022 | Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) top... | cGMP deficiencies | Class II | Mylan Pharmaceuticals Inc |
| Jan 18, 2022 | Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 ... | Failed Dissolution Specification: Dissolution results are below specification limits for the acti... | Class II | Teva Pharmaceuticals USA |
| Jan 14, 2022 | Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only... | Failed Impurities/Degradation Specifications | Class II | Aurobindo Pharma USA Inc. |
| Jan 14, 2022 | Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY,... | CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam. | Class II | Mayne Pharma Inc |
| Jan 12, 2022 | Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Table... | Failed Dissolution Specifications. | Class II | Ascend Laboratories, LLC |
| Jan 11, 2022 | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, ... | Lack of Assurance of Sterility | Class II | Exela Pharma Sciences LLC |
| Jan 11, 2022 | Lung Cleaner (saline eucalyptus) inhaler, 37 oz cans, Manufactured For: The L... | cGMP deviations | Class II | Pharmasol Corporation |
| Jan 10, 2022 | Clobetasol Propionate Foam, 0.05%, packaged in a) 50 g can (NDC 50742-304-50)... | CGMP Deviations | Class II | Ingenus Pharmaceuticals Llc |
| Jan 10, 2022 | Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals US... | Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution. | Class II | Teva Pharmaceuticals USA |
| Jan 7, 2022 | Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by... | Failed Stability Specifications | Class II | VistaPharm, Inc. |
| Jan 5, 2022 | Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous an... | Subpotent Drug: Out of specification for assay at the 30-month stability timepoint. | Class II | Akorn, Inc. |
| Dec 31, 2021 | MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 1... | Lack of Assurance of Sterility | Class II | Teva Pharmaceuticals USA |
| Dec 31, 2021 | Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose... | Lack of Assurance of Sterility | Class II | Teva Pharmaceuticals USA |
| Dec 31, 2021 | Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distrib... | Complaint received of foreign matter (metal) embedded in tablet. | Class II | Rubicon Research Private Limited |
| Dec 30, 2021 | Metformin 750 mg Extended Release NDC # 70518-2920-00 | CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Da... | Class II | RemedyRepack Inc. |
| Dec 29, 2021 | Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b... | Failed Impurities/Degradation Specifications | Class II | RemedyRepack Inc. |
| Dec 29, 2021 | Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo... | Superpotent and Failed Tablet/Capsule Specifications | Class II | Aurobindo Pharma USA Inc. |
| Dec 27, 2021 | Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE ... | CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Da... | Class II | VIONA PHARMACEUTICALS INC |
| Dec 27, 2021 | Nitroglycerin Lingual Spray, 400 mcg per spray, 200 metered sprays, 12 g bott... | Defective Delivery System | Class II | Padagis US LLC |
| Dec 21, 2021 | Cefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem ... | Failed impurities/degradation specifications | Class II | Ascend Laboratories, LLC |
| Dec 21, 2021 | Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single... | Lack of Assurance of Sterility | Class II | Ideal Specialty Apothecary, Inc. dba Ideal Phar... |
| Dec 20, 2021 | Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, R... | Failed Dissolution Specifications | Class II | American Health Packaging |
| Dec 16, 2021 | Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) ... | Subpotent | Class II | Teva Pharmaceuticals USA |
| Dec 8, 2021 | Brinzolamide Ophthalmic Suspension, USP 1%, packaged as a)10 ml dropper bottl... | Defective Container: The notch in the cap that fits into the nozzle of the dropper could break of... | Class II | Teva Pharmaceuticals USA |
| Dec 7, 2021 | Diclofenac Sodium Topical Solution 1.5%, 150 mL, Rx only, Packaged and Distri... | Defective Container: Leaking containers. | Class II | Direct Rx |
| Dec 6, 2021 | Methacholine Challenge 5-Syringe Test Kit, Sterile Inhalation Solution, Prese... | Lack of Assurance of Sterility | Class II | Edge Pharma, LLC |
| Dec 6, 2021 | Cantharidin Gel-Forming Suspension, 0.7%, 10 mL per vial, Multiple Dose Vial ... | CGMP Deviations | Class II | Edge Pharma, LLC |
| Dec 6, 2021 | NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint... | MICROBIAL CONTAMINATION OF NON-STERILE PRODUCT: microbial contaminant identified as Pluralibacter... | Class II | Organics Corporation of America DBA Ambix Labor... |
| Dec 6, 2021 | Phenylephrine HCl 0.5 mg/5mL, (0.1 mg/mL), 5 mL per syringe, Single Use Syrin... | Lack of Assurance of Sterility | Class II | Edge Pharma, LLC |
| Dec 6, 2021 | Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/Ketorolac Sterile Ophthalmic... | Lack of Assurance of Sterility | Class II | Edge Pharma, LLC |
| Dec 6, 2021 | Mitomycin-C, 40mg/40mL (1mg/mL), 40 mL per syringe, Single Dose Syringe for I... | Lack of Assurance of Sterility | Class II | Edge Pharma, LLC |
| Dec 6, 2021 | Phenol, Sterile Solution for Injection (PF), 6%, 5 mL per vial, Single Use Vi... | Lack of Assurance of Sterility | Class II | Edge Pharma, LLC |
| Dec 6, 2021 | Edetate Disodium (EDTA), Sterile Ophthalmic Solution (PF) 1.5%, 10 mL per dro... | Lack of Assurance of Sterility. | Class II | Edge Pharma, LLC |
| Dec 6, 2021 | Physicians CARE Extra Strength PAIN RELIEVER [Acetaminophen, Aspirin (NSAID),... | CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not... | Class II | Medique Products |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.